Srdan Verstovsek, MD, PhD | Authors

August 12, 2022

The panel closes their discussion on myelofibrosis treatment updates by sharing clinical pearls for community oncologists.

August 12, 2022

Experts delve into the unmet needs in the myelofibrosis treatment landscape and highlight promising ongoing clinical trials.

July 29, 2022

A look at sequencing strategies for myelofibrosis treatments.

July 29, 2022

Dr Srdan Verstovsek shares how he assesses myelofibrosis treatment response in his clinical practice.

July 22, 2022

Raajit Rampal, MD, explains how he considers safety profiles when deciding on appropriate treatment for myelofibrosis and how he manages toxicities for patients.

July 22, 2022

A discussion on when to switch a patient with myelofibrosis to a new JAK inhibitor treatment, and possible strategies for transitioning.

July 15, 2022

John Mascarenhas, MD, presents a clinical scenario of a 73-year-old man with myelofibrosis and a low platelet count.

July 15, 2022

A panel of experts considers treatment options for patients with myelofibrosis based on platelet counts, while factoring in health insurance barriers.

July 07, 2022

Raajit Rampal, MD, PhD, shares the treatment options he would consider for the presented clinical scenario.

July 07, 2022

A review of the approved treatments for myelofibrosis, including dosing guidelines and supporting clinical trial data.